Graham Capital Management’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.96M | Buy |
219,084
+82,981
| +61% | +$744K | 0.03% | 327 |
|
|
2025
Q1 | $1.02M | Buy |
136,103
+38,846
| +40% | +$291K | 0.02% | 516 |
|
|
2024
Q4 | $731K | Buy |
+97,257
| New | +$731K | 0.01% | 565 |
|
|
2024
Q1 | – | Sell |
-64,856
| Closed | -$388K | – | 1040 |
|
|
2023
Q4 | $388K | Buy |
64,856
+27,330
| +73% | +$164K | 0.01% | 637 |
|
|
2023
Q3 | $266K | Sell |
37,526
-111
| -0.3% | -$786 | 0.01% | 746 |
|
|
2023
Q2 | $265K | Buy |
+37,637
| New | +$265K | 0.01% | 715 |
|
|
2022
Q4 | – | Sell |
-24,972
| Closed | -$314K | – | 1045 |
|
|
2022
Q3 | $314K | Sell |
24,972
-137,741
| -85% | -$1.73M | 0.01% | 882 |
|
|
2022
Q2 | $1.72M | Buy |
+162,713
| New | +$1.72M | 0.07% | 246 |
|